Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes

Larson, Bruce A.; Fox, Mathew P.; Rosen, Sydney; Bii, Margret; Sigei, Carolyne; Shaffer, Douglas; Sawe, Fredrick; McCoy, Kelly; Wasunna, Monique; Simon, Jonathan L.
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p240
Academic Journal
Background: As access to antiretroviral therapy (ART) has grown in Africa, attention has turned to evaluating the socio-economic impacts of ART. One key issue is the extent to which improvements in health resulting from ART allows individuals to return to work and earn income. Improvements in health from ART may also be associated with reduced impaired presenteeism, which is the loss of productivity when an ill or disabled individual attends work but accomplishes less at his or her usual tasks or shifts to other, possibly less valuable, tasks. Methods: Longitudinal data for this analysis come from company payroll records for 97 HIV-infected tea estate workers (the index group, 56 women, 41 men) and a comparison group of all workers assigned to the same work teams (n = 2485, 1691 men, 794 women) for a 37-month period covering two years before and one year after initiating ART. We used nearest neighbour matching methods to estimate the impacts of HIV/AIDS and ART on three monthly employment outcomes for tea estate workers in Kenya - days plucking tea, days assigned to non-plucking assignments, and kilograms harvested when plucking. Results: The female index group worked 30% fewer days plucking tea monthly than the matched female comparison group during the final 9 months pre-ART. They also worked 87% more days on non-plucking assignments. While the monthly gap between the two groups narrowed after beginning ART, the female index group worked 30% fewer days plucking tea and about 100% more days on non-plucking tasks than the comparison group after one year on ART. The male index group was able to maintain a similar pattern of work as their comparison group except during the initial five months on therapy. Conclusion: Significant impaired presenteeism continued to exist among the female index group after one year on ART. Future research needs to explore further the socio-economic implications of HIV-infected female workers on ART being less productive than the general female workforce over sustained periods of time.


Related Articles

  • CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE.  // PLoS Medicine;Mar2012, Vol. 9 Issue 3, p1 

    Background: Most adults infected with HIV achieve viral suppression within a year of starting combination antiretroviral therapy (cART). It is important to understand the risk of AIDS events or death for patients with a suppressed viral load. Methods and Findings: Using data from the...

  • Efecto de la terapia antirretroviral sobre el perfil lipídico de pacientes con Sida en Maracaibo, estado Zulia, Venezuela.  // Revista Kasmera;jul-dic2010, Vol. 38 Issue 2, p157 

    No abstract available.

  • Adherence to anti-retroviral prophylaxis after occupational and non-occupational exposure to human immunodeficiency virus in patients consulting the Voluntary Counseling and Testing center of Imam Khomeini Hospital, Tehran, 2008-2009. azar Hadadi; Mehrnaz Rasoulinezhad; Saeed Jamali; Seyed Ahmad Seyed Ali naghi; Kousha Paydari; Mohammad Ali Boyer; Esfandiar Shojaie; Alireza Soleymani; Sirous Faraji; Saeed Kalantari; Samaneh Bayrami; Mostafa Hosseini // Journal of School of Public Health & Institute of Public Health ;2012, Vol. 9 Issue 3, p1 

    Background and Aim: The aim of this study was to assess the adherence to anti-retroviral prophylaxis after occupational and non-occupational exposure to human immunodeficiency virus (HIV) in patients consulting the Voluntary Counseling and Testing Center (VCT) of Imam Khomeini Hospital, Tehran...

  • Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America. Chi, Benjamin H.; Yiannoutsos, Constantin T.; Westfall, Andrew O.; Newman, Jamie E.; Zhou, Jialun; Cesar, Carina; Brinkhof, Martin W. G.; Mwango, Albert; Balestre, Eric; Carriquiry, Gabriela; Sirisanthana, Thira; Mukumbi, Henri; Martin, Jeffrey N.; Grimsrud, Anna; Bacon, Melanie; Thiebaut, Rodolphe // PLoS Medicine;Oct2011, Vol. 8 Issue 10, Special section p1 

    Background: Although patient attrition is recognized as a threat to the long-term success of antiretroviral therapy programs worldwide, there is no universal definition for classifying patients as lost to follow-up (LTFU). We analyzed data from health facilities across Africa, Asia, and Latin...

  • ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia. Maldarelli, Frank; Palmer, Sarah; King, Martin S.; Wiegand, Ann; Polis, Michael A.; Mican, JoAnn; Kovacs, Joseph A.; Davey, Richard T.; Rock-Kress, Diane; Dewar, Robin; Shuying Liu; Metcalf, Julia A.; Rehm, Catherine; Brun, Scott C.; Hanna, George J.; Kempf, Dale J.; Coffin, John M.; Mellors, John W. // PLoS Pathogens;Apr2007, Vol. 3 Issue 4, pe46 

    Current antiretroviral therapy is effective in suppressing but not eliminating HIV-1 infection. Understanding the source of viral persistence is essential for developing strategies to eradicate HIV-1 infection. We therefore investigated the level of plasma HIV-1 RNA in patients with viremia...

  • Cancer Burden in the HIV-Infected Population in the United States. Shiels, Meredith S.; Pfeiffer, Ruth M.; Gail, Mitchell H.; Hall, H. Irene; Jianmin Li; Chaturvedi, Anil K.; Bhatia, Kishor; Uldrick, Thomas S.; Yarchoan, Robert; Goedert, James J.; Engels, Eric A. // JNCI: Journal of the National Cancer Institute;May2011, Vol. 103 Issue 9, p753 

    Background Effective antiretroviral therapy has reduced the risk of AIDS and dramatically prolonged the survival of HIV-infected people in the United States. Consequently, an increasing number of HIV-infected people are at risk of non-AIDS-defining cancers that typically occur at older ages. We...

  • Mozambique issues compulsory license for HIV antiretrovirals.  // WHO Drug Information;2004, Vol. 18 Issue 2, p141 

    The HIV/AIDS pandemic constitutes a serious handicap in Mozambique's struggle against hunger, illness, underdevelopment and misery. High rates of morbidity and mortality have put Mozambique among the ten countries in Africa worst hit by HIV. Antiretroviral drugs are available which prolong the...

  • Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection. Mullins, Christopher; Eisen, Geoffrey; Popper, Stephen; Dieng Sarr, Abdoulaye; Sankalé, Jean-Louis; Berger, Judith J.; Wright, Sharon B.; Chang, Hernan R.; Coste, Gérard; Cooley, Timothy P.; Rice, Peter; Skolnik, Paul R.; Sullivan, Margaret; Kanki, Phyllis J. // Clinical Infectious Diseases;6/15/2004, Vol. 38 Issue 12, p1771 

    Human immunodeficiency virus type 2 (HIV-2), the second human retrovirus known to cause AIDS, is endemic to West Africa but is infrequently found outside this region. We present a case series of 10 HIV-2-infected individuals treated in the United States. Physicians applied the principles of...

  • HIV/AIDS.  // Background Notes on Countries of the World: South Africa;May2005, p9 

    Focuses on the prevalence of AIDS in South Africa. Percentage of the population infected with the disease; Estimated number of new HIV infections occurring everyday; Overview of a 2003 national operational plan which outlines provides for a national program for antiretroviral therapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics